Dong‐Xiang Wen

Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma

Xun Zhao, Yu-Jing Liang, Xu Zhang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 40 citations

Systems Biology, Oncology, Tumor Heterogeneity +12

Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

Li‐Ting Liu, Huai Liu, Ying Huang et al. · The Lancet Oncology · 2023 · 37 citations

Concurrent Chemoradiotherapy, Health Sciences, Radiation Therapy +9

Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study

Qing‐Nan Tang, H. Qiu, Xiaoqing Sun et al. · Annals of Translational Medicine · 2021 · 21 citations · Full text

Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus <scp>DNA</scp>

Li‐Ting Liu, Yu‐Jing Liang, Shanshan Guo et al. · Head & Neck · 2021 · 17 citations

Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA

Yu-Jing Liang, Dong‐Xiang Wen, Mei-Juan Luo et al. · European Journal of Cancer · 2021 · 11 citations